Jiarui Liu^1,2*, Yang Han, MM^2,3*, Shunfeng Hu, MM^2,3*, Linquan Zhan, MM^2,3*, Xinting Hu, MM^2,3*, Juan Yang, PhD^2,3*, Shuai Ren, MM^2,3*, Yiqing Cai^2,3*, Xin Wang, MD, PhD^2,3 and Xiangxiang Zhou, MD^1,2*

¹Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
³Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

Ivana Spasevska^1,2*, Sarah Josefsson, PhD, MSc^1,2*, Yngvild Nuvin Blaker, MD, PhD^1,2*, Chloe B. Steen, PhD^3*, Ankush Sharma, PhD^1,2*, Kushi Kushekhar, PhD, MSc^1*, Saskia Meyer, PhD^1*, Arne Kolstad, MD, PhD^4*, Klaus Beiske, MD, PhD^5*, Harald Holte, MD, PhD^2,4, Bjørn Østenstad, MD, PhD^4*, Eva Kimby, MD, PhD⁶, Johanna Olweus, PhD^1*, Kjetil Tasken, PhD^1,2*, Suzanne Lorenz, PhD^7*, Erlend B. Smeland, PhD, MD^1,2*, Ash A. Alizadeh, MD, PhD^8,9, Kanutte Huse, PhD^1,2* and June Helen Myklebust, PhD^1,2

¹Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
²KG Jebsen Centre for B-cell malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
³Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA
⁴Department of Oncology, Oslo University Hospital, Oslo, Norway
⁵Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, NOR
⁶Hematology, Karolinska Institute, Stockholm, Sweden
⁷Genomics Core Facility, Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
⁸Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Stanford, CA
⁹Stanford Cancer Institute, Stanford University Medical Center, Stanford, CA

Marzia Varettoni^1*, Simone Ferrero, MD^2,3, Cristina Picone^1*, Milena Gilestro^4*, Noemí Puig, MD, PhD^5*, Luigi Marcheselli^6*, Irene Dogliotti, MD^2,3*, Angela Ferrari^7*, Michele Merli, MD^8*, Giulia Zamprogna, MD^9*, Luca Laurenti, MD^10*, Simona Tomassetti, MD^11*, Emanuele Cencini, MD^12,13*, Giacomo Loseto, MD^14*, Dario Marino, MD, PhD¹⁵, Monia Marchetti, MD^16*, Francesca Re, MD^17*, Antonello Sica, MD^18*, Jacopo Olivieri^19*, Cristina Jiménez, PhD^5*, Silvia Zibellini, PhD^1*, Daniela Drandi, PhD^2*, Chiara Candido^1*, Martina Ferrante, PhD^20*, Nicole Fabbri^1*, Federica Cavallo^20,21*, Luca Arcaini^1,22*, Mario Boccadoro^2,3 and Ramon Garcia-Sanz⁵

¹Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
³Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
⁴Division of Hematology, A.O.U. Città della Salute e della Scienza, Torino, Italy
⁵Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
⁶Fondazione Italiana Linfomi- c/o Centro Oncologico Modenese (COM), Università di Modena e Reggio Emilia, Modena, Italy
⁷Ematologia, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy
⁸UOC Ematologia, Ospedale di Circolo e Fondazione Macchi – ASST Sette Laghi, Varese, Italy
⁹Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹⁰Sezione di Ematologia, Dipartimento Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A Gemelli, Roma, Italy
¹¹Ematologia, Ospedale degli Infermi di Rimini, Rimini, Italy
¹²Unit of Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy
¹³U.O.C. Ematologia, AOU Senese, Siena, Italy
¹⁴Hematology and Cell Therapy Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
¹⁵Oncologia Medica 1, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy
¹⁶Ematologia, Ospedale Civile SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹⁷UO Ematologia e CTMO, Azienda Ospedaliero Universitaria di Parma, Parma, Italy
¹⁸Oncologia Medica ed Ematologia, AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
¹⁹Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
²⁰Department of Molecular Biotechnologies and Health Sciences, University of Torino, Turin, Italy
²¹A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
²²Department of Molecular Medicine, University of Pavia, Pavia, Italy

Xianhuo Wang, M.D.^1*, Yang Li^1*, Yuhang Hong^1*, Xianming Liu^1*, Lanfang Li^1*, Lihua Qiu^1*, Zhengzi Qian^1*, Shiyong Zhou^1*, Bin Meng^2*, Kai Fu, MD, PhD^3,4 and Huilai Zhang^1*

¹Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
³Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
⁴Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE

Hua Wang, MD

hematological oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Christopher A. Yasenchak, MD¹, Jamyia Clark, PhD, MPH^2*, Nicholas Liu, PharmD^3*, April Beeks, MPH^4*, Michelle A. Fanale, MD³, Nicholas Robert, MDCM^4* and Kristina Yu-Isenberg, PhD, MPH, RPh^3*

¹Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
²McKesson, The Woodlands, TX
³Seattle Genetics, Bothell, WA
⁴McKesson Life Sciences, The Woodlands, TX

Matias Autio, MD^1,2*, Suvi-Katri Leivonen, PhD^1,2, Teijo Pellinen, PhD^3* and Sirpa Leppa, MD, PhD^1,2,4

¹Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
²iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
³Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
⁴Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland

Emine Gulsen Gunes, PhD^1*, Sung Hee Kil, PhD^2*, Xiwei Wu, PhD^3*, Chingyu Su^2*, Zhen Han^2*, Hanjun Qin, PhD^4*, Ting-Fang He, PhD^5*, Jing Chen^5*, Yukiko Yamaguchi, PhD^6*, Jasmine M. Zain, MD⁶, Farah Abdulla, MD^7*, Saul Priceman, PhD^6*, Mingye Feng, PhD^5*, Peter P. Lee, MD⁵, Steven T. Rosen, MD⁶ and Christiane Querfeld, MD, PhD^2,8

¹Department of Hematologic Malilgnancies Translational Science, Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope, Duarte, CA
²Division of Dermatology, Beckman Research Institute, City of Hope, Duarte, CA
³Department of Molecular and Cellular Biology, City of Hope National Medical Center, Duarte, CA
⁴Department of Integrative Genomics Core, Beckman Research Institute, City of Hope, Duarte, CA
⁵Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, CA
⁶Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope, Duarte, CA
⁷Division of Dermatology, City of Hope, Duarte, CA
⁸Department of Pathology, City of Hope, Duarte, CA